At the inauguration of Hadassah's new day care center of the Sidney Weisner Department of Bone Marrow Transplantation and Cancer Immunotherapy today, Prof. Shimon Slavin, head of the department, described an innovative treatment for cancer patients who have previously undergone chemotherapy, surgery and/ or radiotherapy.
The treatment, currently available only at Hadassah, is based on the use of lymphocytes taken from any donor, whether or not the patient's and donor's tissues match. Through a laboratory treatment, these cells are turned into 'cancer Killers'. After transfusion, these cells seek out and destroy any of the patient's remaining cancer cells that survived previous anti-cancer therapies. This treatment is carried out in the Day Care Center of the Bone Marrow Transplantation Department at Hadassah, on an outpatient basis.
The Center, which was inaugurated today in its new premises in the Ullman Building at the Hadassah University Hospital, Ein Kerem, cares for some 4000 patients a year. It was constructed with special attention to amenities and patient comfort, it's wide windows face the magnificent view of the Jerusalem hills.
Adjacent to the Department of Bone Marrow Transplantation and Cancer Immunotherapy, the center attracts patients from all over the world, and offers innovative and exclusive treatments in the fields of cell therapy for cancer and anti-cancer vaccination.